loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Potassium Warfarin

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Potassium Warfarin

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edoxaban Noninferior to Warfarin in Atrial Fibrillation After TAVI
    Edoxaban Noninferior to Warfarin in Atrial Fibrillation After TAVI

    01 Sep 2021

    // ESCARDIO

    https://www.escardio.org/The-ESC/Press-Office/Press-releases/Edoxaban-noninferior-to-warfarin-for-adverse-events-after-heart-valve-replacement

    ESCARDIO
    01 Sep 2021
    Share Share
    Warfarin use significantly increases risk of knee and hip replacement
    Warfarin use significantly increases risk of knee and hip replacement

    10 Nov 2020

    // EUREKALERT

    https://www.eurekalert.org/pub_releases/2020-11/acor-wus110520.php#:~:text=ATLANTA%20%2D%2D%20New%20research%20presented,patients%20with%20osteoarthritis%20(ABSTRACT%20%230934

    EUREKALERT
    10 Nov 2020
    Share Share
    Portola's Announces Results Andexxa was Associated with Lowest Rate of Mortality
    Portola's Announces Results Andexxa was Associated with Lowest Rate of Mortality

    16 Mar 2020

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/portola-pharmaceuticals-announces-results-demonstrating-andexxa-was-associated-with-lowest-rate-of-mortality-in-patients-with-multiple-types-of-factor-xa-inhibitor-related-bleeds-301024484.html

    PR NEWSWIRE
    16 Mar 2020
    Share Share
    XARELTO Reduced the Risk of Strokes in Nonvalvular Atrial Fibrillation
    XARELTO Reduced the Risk of Strokes in Nonvalvular Atrial Fibrillation

    18 Mar 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/xarelto-rivaroxaban-significantly-reduced-the-risk-of-overall-strokes-and-the-most-severe-strokes-and-was-associated-with-fewer-stroke-related-deaths-in-the-real-world-versus-warfarin-in-patients-with-nonvalvular-atrial-fibrill-300813853.html

    PR NEWSWIRE
    18 Mar 2019
    Share Share
    Cereno Scientific driving thrombosis prevention without bleeding-risks
    Cereno Scientific driving thrombosis prevention without bleeding-risks

    06 Dec 2018

    // Jonas Söderström ENDPTS

    https://endpts.com/cereno-scientific-is-driving-a-new-paradigm-of-thrombosis-prevention-without-associated-bleeding-risks/

    Jonas Söderström ENDPTS
    06 Dec 2018
    Share Share
    Increased use of anti-clotting drugs tied to fewer strokes in Afib
    Increased use of anti-clotting drugs tied to fewer strokes in Afib

    25 Sep 2018

    // Lisa Rapaport REUTERS

    https://www.reuters.com/article/us-health-afib-stroke/increased-use-of-anti-clotting-drugs-tied-to-fewer-strokes-in-patients-with-atrial-fibrillation-idUSKCN1M42HY?feedType=RSS&feedName=healthNews

    Lisa Rapaport REUTERS
    25 Sep 2018
    Share Share